Tools & Strategies News

AI for Psychiatric Diagnosis Presents Bias, Clinical Applicability Issues

A new systematic review suggests that artificial intelligence models for psychiatric diagnosis display a high risk for bias and poor clinical applicability.

AI in medical imaging

Source: Getty Images

By Shania Kennedy

- A systematic review published last week in JAMA Network Open evaluating potential risks of translating neuroimaging-based artificial intelligence (AI) models into direct clinical applications, such as psychiatric diagnosis, found that most models must address the risk of bias and other applicability issues prior to implementation in the clinical setting.

The researchers noted that a lack of biomarkers to inform psychiatric diagnostic practices has increased interest in AI- and machine learning (ML)-based neuroimaging approaches. These models aim to enable the use of what the authors call “an objective, symptom-centered, individualized and neurobiologically explicable estimate of psychiatric conditions,” compared to a clinician-based diagnosis, which relies on discrete symptoms.

However, the researchers indicated that the lack of evidence-based evaluations of such tools limits their application in clinical practice.